HCA Financials and Outlook
HCA Healthcare Reports Strong Q2 Revenue Growth, Adjusts FY2026 Sales Guidance.
Anonymous
Key Points
1
HCA narrowed its FY2026 sales guidance to a tighter range of $76.5 billion to $80.0 billion.
2
Q2 2026 revenue was up about 8.7% year over year to roughly $20.23 billion.
3
The company previously reported first-quarter revenue of about $19.109 billion, net income of $1.620 billion and adjusted EBITDA of $3.802 billion.
4
The update to full-year guidance noted that management adjusted its outlook to reflect first-half conditions.
HCA Healthcare posted preliminary second-quarter 2026 revenue of about $20.23 billion, beating Wall Street's estimate of $19.39 billion and marking an 8.7% jump from $18.61 billion a year ago, according to Gurufocus. The strong top-line result, however, came alongside a lowered full-year earnings outlook — and the stock fell roughly 7.3% on the news.
The hospital giant also narrowed its full-year 2026 revenue guidance to a range of $77.0 billion to $79.5 billion, tightening from a prior range of $76.5 billion to $80.0 billion, per Benzinga. The earnings-per-share outlook was cut to $28.70–$30.50 from $29.10–$31.50.
Q2 Results Beat Estimates But Surgeries Slipped
HCA reported net income of about $1.70 billion for the quarter, with diluted earnings per share of $7.62. Adjusted EBITDA — a measure of core operating profit — came in near $4.03 billion. Those numbers beat analyst forecasts on the top line by a wide margin, according to Gurufocus.
Patient volume told a mixed story. Same-facility admissions rose 2.5% and emergency room visits climbed 3.6%. But inpatient and outpatient surgeries both fell compared to the same period last year. HCA said those trends directly shaped its updated full-year outlook.
Full-Year Guidance Cut Reflects First-Half Reality
HCA management said the guidance update reflects conditions seen in the first half of the year, per Benzinga. The company narrowed its revenue band to $77.0 billion–$79.5 billion, centering near the LSEG IBES consensus estimate of $78.64 billion. The tighter range signals less room for upside — or downside — in the back half of 2026.
The earnings-per-share cut was notable. The new range of $28.70 to $30.50 sits below the old floor of $29.10. That downward shift in the profit outlook is what hit the stock hardest, driving shares down about 7.3% on the day of the announcement.
How Q2 2026 Stacks Up Against Recent Quarters
The $20.23 billion Q2 result is a clear step up from the prior quarter. HCA reported first-quarter 2026 revenue of about $19.11 billion, with net income of $1.62 billion and adjusted EBITDA of $3.80 billion. Revenue has now grown each quarter as the company expands its network.
Year over year, the gains are also solid. Q2 2025 revenue was $18.61 billion. That means HCA added roughly $1.62 billion in revenue in just one year. The company operates about 190 hospitals and 2,500 outpatient facilities, handling some 47 million patient encounters annually.
Earnings Call Set for July 24 as Investors Seek Clarity
HCA will host its full second-quarter 2026 earnings conference call on July 24, 2026, at 9:00 a.m. ET, according to Markets Financial Content. The call will be webcast live and archived on the company's website. Investors will be looking for more detail on the surgery volume decline and how management plans to hit its revised targets.
HCA has pointed to ongoing investments in patient care and digitization of its network as key growth drivers. But with surgical volumes down and the EPS ceiling trimmed, the second half of 2026 will need to deliver on those promises to restore investor confidence.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
23
Articles
90
Reach
113
A
AnonymousAuthor